SCHEMBL7874810

SCHEMBL7874810

CCOC(=O)N1CCN(Cc2nc3c(-c4cnc5ccccc5c4)cnn3c(N)c2Br)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 4/20 0.42
TP53 P04637 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42
STAT1 P42224 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KMT2A Q03164 2/20 0.41
CHEK1 O14757 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CCNA1 P78396 1/20 0.41
FAAH O00519 8/20 0.41
LMNA P02545 1/20 0.41
PIK3CA P42336 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893497 0.90 CHEK1 (0.43) CHEK1CCNA2CDK2CCNA1FAAH
SCHEMBL7874808 0.87 FASN (0.44) ALDH1A1KDM4ECHEK1CCNA2CDK2
SCHEMBL6893477 0.86 CHEK1 (0.48) NPC1KMT2ACHEK1CCNA2CDK2
SCHEMBL6894900 0.85 CHEK1 (0.45) NPC1RAB9AKMT2ACHEK1CCNA2
SCHEMBL10234586 0.85 PIK3CA (0.45) ALDH1A1KDM4ETP53NPC1HPGD
SCHEMBL6891839 0.84 CHEK1 (0.43) CHEK1CCNA2CDK2CCNA1FAAH
SCHEMBL7882168 0.83 CHEK1 (0.43) NPC1KMT2ACHEK1CCNA2CDK2
SCHEMBL6893777 0.83 CHEK1 (0.44) NPC1RAB9AKMT2ACHEK1CCNA2
SCHEMBL596083 0.83 CHEK1 (0.44) ALDH1A1KDM4ENPC1HPGDRAB9A
SCHEMBL6894404 0.83 CHEK1 (0.46) NPC1KMT2ACHEK1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-05-10 US disclosed
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-05-10 US disclosed
WO-2010118207-A1 PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS SCHERING CORPORATION (US) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MTOR, RICTOR, RPTOR ALDH1A1 3479/4885KDM4E 1448/4885TP53 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.